Member Info for Energyshares

Congratulations to the Avacta on bringing this life saving delivery system to trials.

Interesting the website mentioned in the RNS is American clinicaltrials.com

Could this have anything to do with Tuffs ?

NASDAQ anyone…..

Congratulations to the Avacta team bringing this life saving delivery system to trials.Interesting the website mentioned in the RNS is American. clinicaltrials.com

Could have something to do with Tuffs?

NASDAQ anyone…….

Still hard to believe UK gov still using this rubbish.

https://www.fda.gov/medical-devices/medical-device-recalls/innova-medical-group-recalls-unauthorized-sars-cov-2-antigen-rapid-qualitative-test-risk-false-test

Not dreaming just invested on what I know about company pipeline,affimers cash in the bank for 2 years and the best IP on AIM
if not UK.
How is that a problem when most of the country are still not back in offices or on furlough Avacta busy ramping up.

Medusa have spent millions so have LG chem, Moderna,Daewoong. Cancer side just starting trials sometimes I have pinch myself I’m not dreaming of the potential of this company.
Invested and chilled.

Oh by the way “Are we there yet”

Everyone is in the same boat.
Invested and waiting .I would rather wait for a monster RNS to move SP than a ODX style RNS telling us what we know.

A few jokes don’t hurt but if your stressed that much just de risk a bit and chill
FFS

Yes he is:
Spotted in Flamingo Land Resort Yorkshire
Tank top and shorts feeding the Turtles & Sealions.

Ophidian
I didn’t say Gates want to buy Avacta

I said he will be watching.
With Affimers doing so well against tropical disease and his foundation want to eradicate tropical diseases ,Avacta's will be on his Radar.
Another great licence deal perhaps for AS.

Avacta has Leeds University as their R&D department a master stroke by AS.
So much talent studying affimers and all for free.

Below another example why Bill Gates will have Avacta on his radar.

Crimean-Congo hemorrhagic fever

https://pubmed.ncbi.nlm.nih.gov/32492018/

Agree
Ncyt will keep falling and Avacta will rocket
When we get elf use.

Looks like the market think PCR is dead
NYCT taking a hit.

If FDA are telling Americans to send them back to Innova for a refund.
Can the UK government send their stocks back and receive a refund for the British Tax payers.

Been reading all day this has got me hooked..
Half my fridge and cupboards are empty now,out of date stuff.
Need to do a big shop now….

Petros Sarantos
Head of Product management Avacta

If COVID-19 rapid antigen testing is to become a true public health tool, it needs to deliver meaningful and credible results.

The Avacta AffiDX SARS-CoV-2 Antigen Lateral Flow Test:
Designed, developed and manufactured in the UK. Validated in the EU and monitored against Variants of Concern (VoC).

Putting quality and performance first in the effort to make Rapid Lateral Flow testing not only accessible but above all, reliable.

Liked by Maria Vittoria Traversa.
GMDP Associate
Danaher Corp

Interesting Petros started working at Avacta after the Cytiva partnership broke down.
Are Cytiva & Danaher still talking to Avacta could they be our USA link for Affidx.

“and is progressing multiple commercial opportunities with distributors and end users in Europe, UK, Asia and elsewhere.”

Europe ….. Tick
UK …… Tick (interesting)
Asia …… Tick
Elsewhere …….
United States ???
Canada ???
South America ???

My money is South America = elsewhere
That’s where Medusa have contacts…..

Dogs80
The driver will phone and tell you he will be with you shortly :)

Big Ego
Do you realise how stupid you sound….

Or a takeover approach. :)

Any one know the answer ?

Is this the test Mologic have given to ODX or is the test they are working on with Avacta.

Or is this another test with nothing to do with ODX or Avacta.

https://bit.ly/3xWT7V6

So after phase 1 AS looking for a major license deal.

“If we see a similar reduction in cardiotoxicity in humans in the planned phase one clinical trial of AVA6000 in 2020, then there is the potential for a major license deal that could generate a transformational, non-dilutive, upfront payment of tens of millions of dollars.

“This funding would support all our other programmes. For this reason, we are prioritising this programme with respect to use of the proceeds of today’s successful placing.”

Wish I had spotted this in Oct 2019.

https://www.thebusinessdesk.com/yorkshire/news/2045636-listed-life-sciences-company-in-bid-to-raise-up-to-9m

Answers the question why they picked Doxorubicin first so they can fund ghd rest of the pipeline.